Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
There is an interesting editorial just published on line in the Journal of Urology and written by Prof. Joseph Smith of Vanderbilt University. Unfortunately, because it is an editorial, there is no abstract, and the text is only accessible if you are a subscriber to the journal. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: da Vinci, responsibility, robot, trust | 7 Comments »
A new paper recently published on line in Urology (“the Gold Journal”) suggests that men with diabetes who are treated with curative intent for localized prostate cancer using external beam radiation therapy may experience higher than normal risk for late genitourinary complications and adverse effects. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: diabetes, external beam, localized, radiation | Leave a Comment »
Last September we asked whether the Oncotype DX test for risk of prostate cancer developed by Genomic Health was “ready for prime time”. In a media release issued earlier this week, the company said that it was. However, there are a number of unresolved issues that are likely to impact the uptake of this new test. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: DX, Oncotype, risk, significant | 3 Comments »
The American Urological Association (AUA) sent the following additional message to its members with the past 90 minutes: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guideline, PSA, screening, testing | 8 Comments »
One of the things that is most interesting about the new guidelines issued by the AUA last week (see here for original announcement) is that they seem to be gaining reasonably widespread approval — probably because they are actually (and finally) based on actual evidence as opposed to raw opinion. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guideline, PSA, risk, screening, testing | 14 Comments »
According to an article just published on line in Prostate, taking statins before a diagnosis of prostate cancer lowers risk for prostate cancer-specific mortality (but does not lower risk for progression/recurrence of prostate cancer after first-line treatment). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, mortality, risk, statin | 2 Comments »
As of 7 am this morning, the American Urological Association (AUA) has issued a new set of guidelines on screening for prostate cancer. The full text of this set of guidelines is already available on the AUA web site. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, screening | 7 Comments »
A podium presentation by Kingman et al. at the upcoming annual meeting of the American Urological Association (AUA) may be among the most significant to be presented at the meeting. It seriously challenges the long-held belief about the need to routinely re-biopsy men initially diagnosed with high-grade prostatic intraepithelial neoplasia (HG-PIN). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, HG-PIN, high-grade, neoplasia, PSA, risk | Leave a Comment »
A paper to be presented at the upcoming AUA annual meeting from what appears to be an ex-US group of clinicians continues to demonstrate the fact that many men get surgical treatment for prostate cancer without anything like a full appreciation of the clinical problem, their treatment options, or the potential consequences. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decision-making, experience, outcome, radical prostatectomy, satisfaction, surgery | 5 Comments »
Another paper to be presented at the upcoming annual meeting of the American Urological Association (AUA) offers us some additional data on the effectiveness and safety of high-intensity focused ultrasound (HIFU) carried out using the Ablatherm technology and recorded in the @-Registry database. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: Ablatherm, focused, HIFU, high-intensity, outcome, ultrasound | 1 Comment »
A new review article in Oncology discusses the potential of multiparametric magnetic resonance imaging (mpMRI) in the diagnosis and management of prostate cancer, and will be useful reading for many advocates and support group leaders. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, imaging, MRI, multiparametric, prognosis | 1 Comment »
A new study just published on line in Clinical Cancer Research shows a degree of correlation between the results of tests for PCA3 and the TMRPSS2-ERG biomarker and risk for progressive disease in men on active surveillance. However, this correlation appears to be less than compelling. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: acgtive surveillance, biomarker, PCA3, risk, TMRPSS2-ERG | Leave a Comment »
A new study to be presented at the upcoming annual meeting of the American Urological Association in San Diego will provide data on the first-line treatment of some 358 men with low-risk prostate cancer collected in the @-Registry, all of whom received treatment with high-intensity focused ultrasound (HIFU) using the Ablatherm® form of this technology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focused, HIFU, high-intensity, low risk, ultrasound | 7 Comments »
In an entirely unsurprising finding, “Despite dietary supplements being popular among prostate cancer patients, a new review of past research says they are not effective treatments for the disease” states a Reuters report published on Friday last week. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: dietary, supplement | 9 Comments »
A story posted yesterday on the Bloomberg News web site suggests that risk associated with severe infections caused by prostate biopsies may be starting to change how urologists carry out prostate biopsies, and even whether to do them in many cases. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biopsy, infection, risk, sepsis | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site